ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Clinical Impact and Evolution of Humoral Immunity in a Randomized Multicenter Trial of Steroid Avoidance in Pediatric Renal Transplantation, The

    M. Sarwal, A. Chadhuri, M. Ozawa, M. Everly, R. Ettenger, V. Dharnidharka, M. Benfield, R. Mathias, A. Portale, R. McDonald, W. Harmon, D. Kershaw, V. Vehaskari, E. Kamil, H. Baluarte, B. Warady, T. Sigdel, H. Szu-chuan, H. Dai, M. Naesens, J. Waskerwitz, O. Salvatierra, P. Terasaki

    California Pacific Medical Center, San Francisco, CA; One Lambda, LA; For the Multicenter SNSO1 study, , CA

    PURPOSE: The development of anti-donor humoral responses after transplantation associates with higher risks for acute rejection and 1-year graft survival in adults, but the influence…
  • 2013 American Transplant Congress

    Strain Specific Induction of Regulatory T Cells by Plasmacytoid Dendritic Cells

    D. Ndishabandi, K. Shinoda, R. Colvin, A. Alessandrini

    Surgery, Massachusetts General Hospital, Boston; Pathology, Massachusetts General Hospital, Boston, MA

    Life sustaining, full MHC-mismatched mouse kidney transplants are spontaneously accepted in certain strain combinations (e.g., DBA/2 to B6), while some full MHC-mismatched mouse kidneys are…
  • 2013 American Transplant Congress

    Belatacept Post-Approval Implementation: A Large Single Center Experience

    A. Adams, C. Garrett, A. Chami, M. Harler, S. Pastan, A. Kirk, T. Pearson, C. Larsen

    Emory Transplant Center, Atlanta, GA; Bristol-Myers Squibb, Princeton, NJ

    Belatacept is a novel CD28 pathway antagonist that was recently approved as a maintenance immunosuppressive agent for kidney transplant recipients. While the pivotal trials for…
  • 2013 American Transplant Congress

    Normative Values for Transplant Health-Related Quality of Life

    D. Radosevich, L. McHugh, H. Doan, R. Bailey, G. Cordner, L. Kathryn, M. Hertz, A. Matas, J. Lake, R. Kandaswamy, M. Colvin-Adams, T. Pruett

    Department of Surgery, University of Minnesota, Minneapolis, MN; Center for Lung Science and Health Medical Director, University of Minnesota, Minneapolis, MN; Department of Medicine, Cardiovascular Division, University of Minnesota, Minneapolis, MN; Transplant Information Services, Fairview Health Services, Minneapolis, MN

    Background. Health-related quality of life (HRQoL) evaluates health from the view point of the individual and preferences the “quality of live versus the quantity of…
  • 2013 American Transplant Congress

    False Hepatitis C Antibody Development in Left Ventricular Assist Device Recipients Who Proceed to Heart Transplantation

    D. Lee, D. Levy, J. Shuter, G. Minamoto, D. Goldstein, D. D'Alessandro, V. Muggia

    Medicine, Division of Infectious Disease, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY; Cardiovascular and Thoracic Surgery, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY

    Purpose: Ventricular assist devices (VAD) have been shown to lead to immune activation and higher frequencies of autoantibodies. Previous research reports a rate of 30%…
  • 2013 American Transplant Congress

    Altered Serum miR-326 and miR-142-3p Profiles during Acute Rejection after Heart Transplantation

    I. Dewi, K. Torngren, O. Gidlöf, B. Kornhall, J. Öhman

    Department of Cardiology, Lund University, Lund, Sweden; Clinic of Heart Failure and Valvular Disease, Skåne University Hospital, Lund, Sweden

    IntroductionCirculating miRNAs may serve the purpose as practicable non-invasive biological marker of allograft status in heart transplanted patients, as they can be detected in serum…
  • 2013 American Transplant Congress

    Rituximab To Prevent Renal Allograft Rejection; a Randomized, Double-Blind, Placebo-Controlled Trial

    M. van den Hoogen, E. Steenbergen, A. Hoitsma, L. Hilbrands

    Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

    BackgroundAnti-B-cell therapy could reduce the incidence of acute renal allograft rejection, especially in immunized patients. This study evaluated the efficacy and safety of rituximab added…
  • 2013 American Transplant Congress

    Thymoglobulin (rATG) Induction Improves Survival in Heart Transplant Recipients: A Retrospective Single-Center Study

    T. Jarmi, A. Naif, M. Weston

    College of Pharmacy, University of South Florida, Tampa, FL; Internal Medicine, University of South Florida, Tampa, FL; Tampa General Hospital, Tampa, FL

    A: Our study is a retrospective analysis of heart transplant recipients transplanted in 2009 and were induced with rATG vs. no induction. We hypothesized that…
  • 2013 American Transplant Congress

    Time in the Operating Room Independently Predicts Blood Utilization, Charges, and a Cost Efficient Practice

    R. Gilroy, S. Kumer, J. Kindscher, T. Giacoma, E. Charlton, W. Dunn, T. Schmitt

    Center for Transplantation, University of Kansas Medical Center, Kansas City, KS

    BACKGROUND: In an era of economic reform we see clinical practice under increasing performance oversight. To date few studies that have looked specifically at clinical…
  • 2013 American Transplant Congress

    Comparison of Histamine Receptor Antagonists Versus Proton Pump Inhibitor Stress Ulcer Prophylaxis in Kidney Transplant Recipients, A

    G. Morris, K. Hardinger, D. Tsapepas, E. Tichy

    Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT; Department of Pharmacy, Columbia University Medical Center, New York, NY; School of Pharmacy, University of Missouri- Kansas City, Kansas City, MO

    Purpose: Histamine-2 receptor antagonists (H2RA) or proton pump inhibitors (PPI) are often utilized for stress ulcer prophylaxis in kidney transplant (KTx) recipients. The purpose of…
  • « Previous Page
  • 1
  • …
  • 1680
  • 1681
  • 1682
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences